N
SPRB

Nuveen’s Spruce Biosciences SPRB Stock Holding History

Nuveen’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-155
Closed -$24K – 3521
2022
Q1 		$24K Hold
155
– – ﹤0.01% 3292
2021
Q4 		$29K Sell
155
-152
-50% -$45.2K ﹤0.01% 3312
2021
Q3 		$164K Sell
307
-88
-22% -$55.3K ﹤0.01% 3290
2021
Q2 		$332K Buy
395
+243
+160% +$259K ﹤0.01% 3214
2021
Q1 		$190K Sell
152
-150
-50% -$230K ﹤0.01% 3246
2020
Q4 		$551K Buy
+302
New +$501K ﹤0.01% 3023

Other funds holding SPRB

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nuveen's SPRB Position: Q2 2022 in Review

Nuveen sold out of Spruce Biosciences (SPRB) in Q2 2022, closing a stake of 155 shares — an estimated $24K sold.

Nuveen first reported a position in SPRB in Q4 2020 and held it in 6 quarters. The position peaked at $551K in Q4 2020. 36 funds tracked by Wall St. Rank hold SPRB as of Q2 2022.

  • Nuveen reported no remaining Spruce Biosciences position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 155 Spruce Biosciences shares in Q2 2022, an estimated $24K.
  • Nuveen first reported a position in Spruce Biosciences in Q4 2020 and held it in 6 quarters.
  • Nuveen's Spruce Biosciences position peaked at $551K in Q4 2020.
  • 36 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.